GraniteShares YieldBOOST Biotech ETF

Frequently Asked Questions About BIOY

What does BIOY invest in?

The GraniteShares YieldBOOST Biotech ETF, an exchange-traded fund launched by GraniteShares Inc. under the umbrella of the GraniteShares ETF Trust, is managed by GraniteShares Advisors LLC. This U.S.-domiciled fund primarily allocates capital to the public stock markets within the United States. Its investment approach involves constructing its portfolio using derivative instruments, such as options, to gain exposure to companies operating across the healthcare, pharmaceutical, biotechnology, and life sciences industries. The ETF seeks a diverse selection of both growth and value stocks, encompassing businesses of varying market capitalizations.

What is the expense ratio of BIOY?

GraniteShares YieldBOOST Biotech ETF (BIOY) charges an expense ratio of 1.07%. This is the annual fee deducted from fund assets to cover management and operations.

What is BIOY's distribution yield?

BIOY's trailing-twelve-month yield is 32.57%, calculated from the sum of distributions over the past year divided by the current price. A rate this high reflects large option-premium distributions against a NAV that has declined over the same period. Part of each payout may be return of capital rather than earned income.

How does BIOY's covered-call strategy work?

BIOY sells call options against the stocks (or index) it holds, collecting premium income that gets passed through to shareholders as distributions. The strategy generates above-market income in flat or rising markets but caps upside. When the underlying rallies past the strike, the gains above the strike go to the option buyer, not the fund.

How big is BIOY?

GraniteShares YieldBOOST Biotech ETF (BIOY) manages $1.5M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation.

Is BIOY actively managed or an index fund?

BIOY's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.